Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings

Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings News provided by Bio-K+, A Kerry Company May 11, 2026, 10:05 ET Share this article Share to X Share this article Share to X Experience the full interactive Multichannel News Release here: https://www.multivu.com/biokplus/9393551-en-biokplus-gut-health-autism-spectrum-disorder-probiotic-solutions-study MONTREAL , May 11, 2026 /PRNewswire/ - Bio-K+ ® , a leader in scientifically supported probiotic solutions, announced encouraging findings from an ongoing clinical research initiative exploring the role of gut microbiome in children living with Autism Spectrum Disorder (ASD). Conducted in collaboration with researchers at the CHU Sainte-Justine Research Centre in Montreal, and supported by the Canadian Institutes of Health Research (CIHR) , the work contributes to growing research on the gut-brain axis; the bidirectional connection between the gut microbiome and brain function. Continue Reading Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings (CNW Group/Bio-K+, A Kerry Company) Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings (CNW Group/Bio-K+, A Kerry Company) Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings (CNW Group/Bio-K+, A Kerry Company) Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings (CNW Group/Bio-K+, A Kerry Company)